Molecular changes occurring during reverse remodelling following left ventricular assist device support

Journal of Cardiovascular Translational Research

Volumn 3, Issue 6, 2010, Pages 635-642

  Birks, Emma J ^a   George, Robert S ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Fibrosis; Left ventricular assist devices; Molecular; Myocyte; Recovery

Indexed keywords

ANIMAL; CONVALESCENCE; DEVICE REMOVAL; EXTRACELLULAR MATRIX; HEART ASSIST DEVICE; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW; TIME; TREATMENT OUTCOME;

ANIMALS; DEVICE REMOVAL; EXTRACELLULAR MATRIX; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MYOCYTES, CARDIAC; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 79952780873     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-010-9220-8     Document Type: Article

References (68)

1. Colucci, W. S. (1997). Molecular and cellular mechanisms of myocardial failure. The American Journal of Cardiology, 80 (11A), 15L-25L.
2. Cohn, J. N. (2005). Critical review of heart failure: The role of left ventricular remodeling in the therapeutic response. Clinical Cardiology, 18(Suppl IV), IV-4-IV-12.
3. Swynghedauw, B. (1999). Molecular mechanisms of myocardial remodeling. Physiological Reviews, 79(1), 216-248.
4. Bozkurt, B. (1999). Medical and surgical therapy for cardiac remodeling. Current Opinion in Cardiology, 14, 196-205.
5. Cleutjens, J. P., Kandala, J. C., Guarda, E., Guntaka, R. V., & Weber, K. T. (1995). Regulation of collagen degradation in the rat myocardium after infarction. Journal of Molecular and Cellular Cardiology, 27(6), 1281-1292.
6. Katz, A. M. (1994). The cardiomyoapthy of overload: An unnatural growth response in the hypertrophied heart. Annals of Internal Medicine, 121(5), 363-371.
7. Gaballa, M. A., & Goldman, S. (2002). Ventricular remodelling in heart failure. Journal of Cardiac Failure, 8 (6 (Suppl)), S476-S485.
8. Yacoub, M. H. (2001). A novel strategy to maximise the efficacy of left ventricular assist devices as a bridge to recovery. European Heart Journal, 22(7), 534-540.
9. Olivetti, G., Capasso, J. M., Sonnenblick, E. H., & Anversa, P. (1990). Sise-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circulation Research, 67 (1), 23-34. (Pubitemid 20223724)
10. Hirohata, S., Kusachi, S., Murakami, M., et al. (1997). Time dependent alterations of serum matrix metalloprotainase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction. Heart, 78 (3), 278-284. (Pubitemid 27431737)
11. Terracciano, C. M. N., Hardy, J., Birks, E. J., Khaghani, A., Banner, N. R., & Yacoub, M. H. (2004). Clinical recovery from end-stage heart failure using Left Ventricular Assist Device and Pharmacologic Therapy correlates with increased sarcoplasmic reticulum calcium content, but not with regression of cellular hypertrophy. Circulation, 109, 2263-2265. (Pubitemid 38656863)
12. Narula, J., Haider, N., Virmani, R., et al. (1996). Apoptosis in myocytes in end-stage heart failure. New England Journal of Medecine, 335, 1182-1189. (Pubitemid 26339772)
13. Seta, Y., Shan, K., Bozkurt, B., Oral, H., & Mann, D. L. (1996). Basic mechanisms in heart failure: The cytokine hypothesis. Journal of Cardiac Failure, 2, 243-249.
14. Sivasubramanian, N., Coker, M. L., Kurrelmeyer, K. M., et al. (2001). Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation, 104, 826-831. (Pubitemid 32762683)
15. Li, Y. Y., Feng, Y. Q., Kadokami, T., et al. (2000). Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor can be modulated by anti-tumor necrosis factor therapy. Proceedings of the National Academy of Science, 97, 12746-12751.
16. Weber, K. T. (1989). Cardiac interstitium in health and disease: The fibrillar collagen. Journal of the American College of Cardiology, 1637, 1652.
17. Conrad, C. H., Brooks, W. W., Hayes, J. A., Sen, S., Robinson, K. G., & Bing, O. H. L. (1995). Myocardial fibrosis and stiffness with hypertrohy and heart failure in the spontaneously hypertensive rat. Circulation, 91, 161-170.
18. Terracio, L., Rubin, K., Gullberg, D., et al. (1991). Expression of collagen binding integrins during cardiac development and hypertrophy. Circulation Research, 68, 734-744.
19. Ino, T., Kishiro, M., Okubo, M., et al. (1997). Late persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis. Cardiovascular Research, 34(2), 323-328. (Pubitemid 27241577)
20. Levin, H. R., Oz, M. C., Chen, J. M., Packer, M., Rose, E. A., & Burkhoff, D. (1995). Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circualtion, 91(11), 2717-2720.
21. Birks, E. J., Tansley, P. D., Hardy, J., George, R. S., Bowles, C. T., Burke, M., et al. (2006). Left ventricular assist device and drug therapy for the reversal of heart failure. New England Journal of Medicine, 355(18), 1873-1884. (Pubitemid 44664645)
22. George, R. S., Sabharwal, N. K., Webb, C., et al. (2009). (Abstr). Echocardiographic evaluation of flow across HeartMate II axial flow LVADs at varying low speeds. The Journal of Heart and Lung Transplantation, 28, 2S.
23. Birks, E. J., George, R. S., Hedger, M., et al. (2009). (Abstr). Myocardial recovery from advanced heart failure using the Heartmate II LVAD combined with drug therapy: Early results from a prospective study. The Journal of Heart and Lung Transplantation, 28, 2S.
24. Klotz, S., Jan Danser, A. H., & Burkhoff, D. (2008). Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Progress in Biophysics and Molecular Biology, 97, 479-496.
25. Wohlschlaeger, J., Schmitz, K. J., Schmid, C., et al. (2005). Reverse remodeling following insertion of left ventricular assist devices (LVAD): A review of the morphological and molecular changes. Cardiovascular Research, 68(3), 376-386. (Pubitemid 41566557)
26. Hetzer, R., Muller, J. H., Weng, Y. G., Loebe, M., & Wallukat, G. (2000). Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from endstage dilated cardiomyopathy. The Journal of Thoracic and Cardiovascular Surgery, 120(5), 843-853.
27. Hummel, M., Czerlinski, S., Friedel, N., et al. (1994). Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation. Critical Care Medicine, 22(3), 448-454. (Pubitemid 24085297)
28. Altemose, G. T., Gritsus, V., Jeevanandam, V., Goldman, B., & Margulies, K. B. (1997). Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. The Journal of Heart and Lung Transplantation, 16(7), 765-773. (Pubitemid 27319153)
29. Wallukat, G., & Wollenberger, A. (1987). Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biomedica Biochimica Acta, 46(8-9), S634-S639.
30. Wallukat, G., Wollenberger, A., Morwinski, R., & Pitschner, H. F. (1995). Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loops. Journal of Molecular and Cellular Cardiology, 27(1), 397-406.
31. Loebe, M., Weng, Y., Muller, J., et al. (1997). Successful mechanical circulatory support for more than two years with a left ventricular assist device in a patient with dilated cardiomyopathy. The Journal of Heart and Lung Transplantation, 16(11), 1176-1179. (Pubitemid 27506307)
32. Muller, J., Wallukat, G., Weng, Y. G., et al. (1997). Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation, 96 (2), 542-549. (Pubitemid 27329431)
33. Dipla, K., Mattiello, J. A., Jeevanandam, V., Houser, S. R., & Margulies, K. B. (1998). Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation, 97, 2316-2322. (Pubitemid 28280385)
34. Khan, N., Delgado, R. M., Radovancevic, B., et al. (2003). Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): Hemodynamic and histologic evidence of improvement before LVAD explantation. The Journal of Heart and Lung Transplantation, 22(2), 137-146. (Pubitemid 36173670)
35. Xydas, S., Rosen, R., Ng, C., et al. (2006). Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. Circulation, 25(1), 7-15. (Pubitemid 43049658)
36. Zafeiridis, A., Jeevanandam, V., Houser, S. R., & Margulies, K. B. (1998). Regression of cellular hypertrophy after left ventricular assist device support. Circulation, 98, 656-662. (Pubitemid 28387492)
37. Bruckner, B. A., Stetson, S. J., Perez-Verdia, A., et al. (2001). Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. The Journal of Heart and Lung Transplantation, 20(4), 457-464. (Pubitemid 32297756)
38. Cascino, I., Papoff, G., De Maria, R., Testi, R., & Ruberti, G. (1996). Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. Journal of Immunology, 156(1), 13-17. (Pubitemid 26006942)
39. Schumann, H., Morawietz, H., Hakim, K., et al. (1997). Alternative splicing of the primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium. Biochemical and Biophysical Research Communications, 239(3), 794-798. (Pubitemid 27504181)
40. Bartling, B., Milting, H., Schumann, H., et al. (1999). Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation, 100(19Suppl), II216-II223. (Pubitemid 29523538)
41. Milting, H., Bartling, B., Schumann, H., et al. (1999). Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy - First results of the Halle Assist Induced Recovery Study (HAIR). Thoracic and Cardiovascular Surgeon, 47(1), 48-50. (Pubitemid 29157011)
42. Chen, Y., Park, S., Li, Y., et al. (2003). Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiological Genomics, 14(3), 251-260. (Pubitemid 37345233)
43. Klotz, S., Foronjy, R. F., Dickstein, M. L., et al. (2005). Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circualtion, 112, 364-374. (Pubitemid 41022077)
44. Bruggink, A. H., van Oosterhout, M. F., de Jonge, N., et al. (2006). Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. The Journal of Heart and Lung Transplantation, 25(9), 1091-1098. (Pubitemid 44311529)
45. Felkin, L. E., Taegtmeyer, A. B., & Barton, P. J. R. (2006). Realtime quantitative PCR in cardiac transplant research. In P. Hornick & M. L. Rose (Eds.), Transplantation immunology: Methods and protocols (pp. 305-329). Totowa: Humana Press.
46. Li, Y. Y., Feng, Y., McTiernan, C. F., et al. (2001). Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation, 104, 1147-1152. (Pubitemid 32830399)
47. Kuhn, M., Voß, M., Mitko, D., et al. (2004). Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovascular Research, 64, 308-314. (Pubitemid 39361692)
48. Estrada-Quintero, T., Uretsky, B. F., Murali, S., Griffith, B. P., & Kormos, R. L. (1995). Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. Chest, 107, 1499-1503.
49. James, K. B., McCarthy, P. M., Thomas, J. D., et al. (1995). Effect of implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation, 92, II-191-II-195.
50. Pandalai, P. K., Bulcao, C. F., Merrill, W. H., & Akhter, S. A. (2006). Restoration of myocardial β-adrenergic receptor signaling after left ventricular assist device support. The Journal of Thoracic and Cardiovascular Surgery, 131(5), 975-980.
51. Ogletree-Hughes, M. L., Stull, L. B., Sweet, W. E., Smedira, N. G., McCarthy, P. M., & Moravec, C. (2001). Mechanical unloading restores β-adrenergic responsiveness and reserves receptor downregulation in the failing human heart. Circulation, 104, 881-886. (Pubitemid 32778037)
52. Klotz, S., Barbone, A., Reiken, S., et al. (2005). Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. Journal of the American College of Cardiology, 45, 668-676. (Pubitemid 40278964)
53. Grigore, A., Poindexter, B., Vaughn, W. K., et al. (2005). Alterations in alpha adrenoceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device. The Journal of Heart and Lung Transplantation, 24(5), 609-613. (Pubitemid 40693885)
54. Ortiz-Lopez, R., Li, H., Su, J., Goytia, V., & Towbin, J. A. (1997). Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circualtion, 95(10), 2434-2440. (Pubitemid 27224739)
55. Towbin, J. A., Hejtmancik, J. F., Brink, P., et al. (1993). X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circualtion, 87(6), 1854-1865. (Pubitemid 23165627)
56. Vatta, M., Stetson, S., Perez-Verdia, A., et al. (2002). Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet, 359(9310), 936-941. (Pubitemid 34246384)
57. Terracciano, C. M. N., Harding, S. E., Tansley, P. T., Birks, E. J., Barton, P. J. R., & Yacoub, M. H. (2003). Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. European Heart Journal, 24, 1329-1339. (Pubitemid 36917704)
58. Birks, E. J., Hall, J. L., Barton, P. J., et al. (2005). Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation, 112(9 Suppl), 57-64.
59. Latif, N., Yacoub, M. H., George, R., Barton, P. J. R., & Birks, E. J. (2007). Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during myocardial recovery after left ventricular assist device support. The Journal of Heart and Lung Transplantation, 26(3), 230-235. (Pubitemid 46341890)
60. Cullen, M. E., Yuen, A. H., Felkin, L. E., et al. (2006). Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized following recovery: Potential implications for local creatine synthesis. Circulation, 114, 16-20.
61. Barton, P. J., Felkin, L. E., Birks, E. J., et al. (2010). Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation, 112(9 Suppl), I46-I50. (Pubitemid 41266652)
62. Lara-Pezzi, E., Felkin, L. E., Birks, E. J., et al. (2008). Expression of follistatin-related genes is altered in heart failure. Endocrinology, 149(11), 5822-5827.
63. Felkin, L. E., Lara-Pezzi, E., George, R., Yacoub, M. H., Birks, E. J., & Barton, P. J. (2009). Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support. The Journal of Heart and Lung Transplantation, 28(2), 117-122.
64. Segura, A. M., Frazier, O. H., Demirozu, Z., Buja, L. M. (2010) Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device. Cardiovasc Pathol. doi:10.1016/j.carpath.2010. 01.011.
65. Hall, J. L., Birks, E. J., Grindle, S., Cullen, M. E., Barton, P. J., Rider, J. E., et al. (2007). Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. European Heart Journal, 28 (5), 613-627. (Pubitemid 47355497)
66. 2+ exchanger in reverse remodeling: Relevance for LVAD-recovery. Annals of the New York Academy of Sciences, 1099, 349-360.
67. Stagg, M. A., Malik, A. H., MacLead, K. T., & Terracciano, C. M. (2004). The effects of overexpression of the Na+/Ca2+ exchanger on calcium regulation in hypertrophied mouse cardiac myocytes. Cell Calcium, 36(2), 111-118. (Pubitemid 38950063)
68. Francis, G. S., & Wilson Tang, W. H. (2003). Pathophysiology of congestive heart failure. Reviews in Cardiovascular Medicine, 4 (Suppl 2), S14-S20. (Pubitemid 36701293)